Fresenius Medical offers long five-, 10-year notes; price talk set

By Cristal Cody

Chicago, May 12 – Fresenius Medical US Finance III Inc. is in the dollar market on Wednesday with a two-part offering of fixed-rate notes.

The company plans to sell a tranche of notes due Dec. 1, 2026 with talk in the Treasuries plus 125 basis points area and a longer-dated tranche of notes due Dec. 1, 2031 with talk in the Treasuries plus 155 bps area, according to information from a market source.

Citigroup, Goldman Sachs, JPMorgan and Wells Fargo Securities are handling the offer.

The issuer is a kidney dialysis company based in Bad Homburg, Germany.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.